NEW USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT

• 收藏
• 分享

专利权人:

XIGEN INFLAMMATION LTD.

发明人:

COMBETTE, JEAN-MARC,DELOCHE, CATHERINE

申请号：

CA2987365

公开号：

CA2987365A1

申请日:

2016.06.24

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun N-terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the prevention and/or treatment of Mild Cognitive Impairment, in particular of Mild Cognitive Impairment due to Alzheimers Disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/